1uui: Difference between revisions
From Proteopedia
Jump to navigationJump to search
New page: left|200px<br /> <applet load="1uui" size="450" color="white" frame="true" align="right" spinBox="true" caption="1uui" /> '''NMR STRUCTURE OF A SYNTHETIC SMALL MOLECULE... |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:1uui.gif|left|200px]]<br /> | [[Image:1uui.gif|left|200px]]<br /><applet load="1uui" size="350" color="white" frame="true" align="right" spinBox="true" | ||
<applet load="1uui" size=" | |||
caption="1uui" /> | caption="1uui" /> | ||
'''NMR STRUCTURE OF A SYNTHETIC SMALL MOLECULE, RBT158, BOUND TO HIV-1 TAR RNA'''<br /> | '''NMR STRUCTURE OF A SYNTHETIC SMALL MOLECULE, RBT158, BOUND TO HIV-1 TAR RNA'''<br /> | ||
==Overview== | ==Overview== | ||
The targeting of RNA for the design of novel anti-viral compounds has | The targeting of RNA for the design of novel anti-viral compounds has until now proceeded largely without incorporating direct input from structure-based design methodology, partly because of lack of structural data, and complications arising from substrate flexibility. We propose a paradigm to explain the physical mechanism for ligand-induced refolding of trans-activation response element (TAR RNA) from human immunodeficiency virus 1 (HIV-1). Based upon Poisson-Boltzmann analysis of the TAR structure, as bound by a peptide derived from the transcriptional activator protein, Tat, our hypothesis shows that two specific electrostatic interactions are necessary to stabilise the conformation. This result contradicts the belief that a single argininamide residue is responsible for stabilising the TAR fold, as well as the conventional wisdom that electrostatic interactions with RNA are non-specific or dominated by phosphates. We test this hypothesis by using NMR and computational methods to model the interaction of a series of novel inhibitors of the in vitro RNA-binding activities for a peptide derived from Tat. A subset of inhibitors, including the bis-guanidine compound rbt203 and its analogues, induce a conformation in TAR similar to that brought about by the protein. Comparison of the interactions of two of these ligands with the RNA and structure-activity relationships observed within the compound series, confirm the importance of the two specific electrostatic interactions in the stabilisation of the Tat-bound RNA conformation. This work illustrates how the use of medicinal chemistry and structural analysis can provide a rational basis for prediction of ligand-induced conformational change, a necessary step towards the application of structure-based methods in the design of novel RNA or protein-binding drugs. | ||
==About this Structure== | ==About this Structure== | ||
1UUI is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/ ] with P12 as [http://en.wikipedia.org/wiki/ligand ligand]. Full crystallographic information is available from [http:// | 1UUI is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/ ] with <scene name='pdbligand=P12:'>P12</scene> as [http://en.wikipedia.org/wiki/ligand ligand]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1UUI OCA]. | ||
==Reference== | ==Reference== | ||
| Line 17: | Line 16: | ||
[[Category: Bower, J.]] | [[Category: Bower, J.]] | ||
[[Category: Davis, B.]] | [[Category: Davis, B.]] | ||
[[Category: Drysdale, M | [[Category: Drysdale, M J.]] | ||
[[Category: Karn, J.]] | [[Category: Karn, J.]] | ||
[[Category: Lentzen, G.]] | [[Category: Lentzen, G.]] | ||
[[Category: Murchie, A | [[Category: Murchie, A I.H.]] | ||
[[Category: Potter, A | [[Category: Potter, A J.]] | ||
[[Category: Varani, G.]] | [[Category: Varani, G.]] | ||
[[Category: P12]] | [[Category: P12]] | ||
| Line 31: | Line 30: | ||
[[Category: tar rna]] | [[Category: tar rna]] | ||
''Page seeded by [http:// | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 15:28:28 2008'' | ||